Table 2. Comparison of metabolic changes with metformin treatment in the ovarian tumors from obese and lean KpB mice.
Sub-Pathway | Biochemical Name | Lean-Met/Lean-Ctrl* | Obese-Met/Obese-Ctrl* |
---|---|---|---|
Glycolysis | Glucose | 2.75 | 0.46 |
Glucose-6-phosphate | 0.91 | 1.82 | |
Fructose-6-phosphate | 0.87 | 2.3 | |
Fructose-1-6-bisphosphate | 0.68 | 2.4 | |
2,3-diphosphoglycerate | 1.34 | 13.86 | |
Dihydroxyacetone phosphate | 0.64 | 2.44 | |
Phosphoenolpyruvate | 2.99 | 1.7 | |
Pyruvate | 0.27 | 1.36 | |
Lactate | 0.82 | 1.35 | |
TCA Cycle | Citrate | 0.46 | 0.94 |
Alpha-ketoglutarate | 1.23 | 1.53 | |
Succinylcarnitine | 3.6 | 2.44 | |
Succinate | 3.29 | 0.22 | |
Fumarate | 0.73 | 1.57 | |
Malate | 0.8 | 1.4 | |
Glutamine | α-ketoglutarate | 1.23 | 1.53 |
Oxidation | Glucosamine-6-phosphate | 0.65 | 1.8 |
N-acetylglucosamine-6-phosphate | 0.56 | 2.13 | |
n3 and n6 | Eicosapentaenoate | 0.54 | 1.12 |
Fatty Acids | Docosapentaenoate | 0.48 | 1.94 |
Docosahexaenoate | 0.69 | 1.97 | |
Dihomo-linolenate | 0.99 | 2.23 | |
Arachidonate | 0.90 | 2.28 | |
Adrenate | 0.51 | 2.1 | |
Docosapentaenoate | 0.72 | 3.75 | |
Docosadienoate | 0.57 | 1.83 | |
Lysolipids | 1-arachidonoylglycerophophocholine | 1.5 | 2.6 |
1-palmitoylplasmenylethanolamine | 0.82 | 3.24 | |
1-stearoylplasmenylethanolamine | 0.96 | 3.38 | |
1-oleoylplasmenylethanolamine | 0.72 | 2.82 | |
1-palmitoylglycerophosphoethanolamine | 0.87 | 3.0 | |
1-stearoylglycerophosphoethanolamine | 0.72 | 2.21 | |
2-stearoylglycerophosphoethanolamine | 0.57 | 2.68 | |
1-oleoylglycerophosphoethanolamine | 1.18 | 2.72 | |
1-palmitoylglycerophosphoinositol | 1.16 | 4.71 | |
1-stearoylglycerophosphoinositol | 0.86 | 2.8 | |
1-arachidonoylglycerophosphoinositol | 0.23 | 2.64 | |
1-stearoylglycerophosphoserine | 2.15 | 2.5 | |
1-oleoylglycerophosphoserine | 1.88 | 3.15 |
*dark green and red = p<0.05, light green and pink = p<0.1.